Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:50:23 EST Fri 14 Nov 2025
Enter Symbol
or Name
USA
CA



E:CYBN - CYBIN INC. - https://www.cybin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CYBN - E  0.18.25·8.491.08.32-0.75-8.3    19.46  6.95Nov 13Nov 1315 min
NEO - E0.18.25·8.491.0 19.46  6.95Nov 1315 min

Recent Trades - All 0 today
Time ETExPriceChangeVolumeBuyerSellerMarkers
        
        
        
        
        
        
        
        
        
        

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-11-13 07:20C:CYBN9.03News ReleaseCybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights
2025-11-13 07:09C:CYBN9.03SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-13 07:03C:CYBN9.03SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 07:30C:CYBN8.90News ReleaseCybin to Participate in the Jefferies Global Healthcare Conference in London
2025-11-06 16:20C:CYBN8.63News ReleaseCybin to host fiscal Q2 results call Nov. 13
2025-11-05 07:30C:CYBN8.70News ReleaseCybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
2025-11-03 07:30C:CYBN10.05News ReleaseCybin to Participate at the 2025 Milken Institute Future of Health Summit
2025-10-31 19:00C:CYBN10.05News ReleaseCybin closes $175-million (U.S.) offering
2025-10-28 18:34C:CYBN9.85News ReleaseCybin arranges $175-million (U.S.) offering
2025-10-28 08:11C:CYBN9.03News ReleaseCanadian Investment Regulatory Organization Trade Resumption - CYBN
2025-10-28 08:01C:CYBN9.03News ReleaseCanadian Investment Regulatory Organization Trading Halt - CYBN
2025-09-23 20:08C:CYBN8.89News ReleaseCybin plans to enroll 220 participants for CYB003 study
2025-09-11 07:30C:CYBN8.72News ReleaseCybin to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
2025-09-08 18:05C:CYBN8.70News ReleaseCybin completes enrolment in phase 2 study on CYB004
2025-09-04 07:30C:CYBN8.30News ReleaseCybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
2025-09-03 07:30C:CYBN8.70News ReleaseCybin to Participate in the Cantor Global Healthcare Conference 2025
2025-09-02 19:11C:CYBN8.70News ReleaseCybin CEO Drysdale steps down; So appointed in interim
2025-08-26 16:17C:CYBN10.30News ReleaseCybin wins Australian approval for phase 3 MDD study
2025-08-19 03:56C:CYBN9.55News ReleaseCybin shareholders elect six directors at AGM
2025-08-13 17:30C:CYBN10.40News ReleaseCybin Reports Important Progress on Key Milestones and First Quarter Fiscal Year 2026 Financial Results